1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Cancer Analysis & Statistics, May 2019

Global Cancer Analysis & Statistics, May 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

1-30 of about 1200 reports

Cancer Registry Software Market by Type, Delivery, Database, Functionality, End User, Region - Global Forecast to 2024

Cancer Registry Software Market by Type, Delivery, Database, Functionality, End User, Region - Global Forecast to 2024

  • $ 11000
  • Industry report
  • March 2019

Cancer patient registry software market projected to grow at a CAGR of 10.4%The cancer patient registry software market is projected to reach USD 91 million by 2024 from USD 55 million in 2019, at a CAGR ...

  • Industries : Cancer, Pathology, Software
  • Countries : United States, North America
Chimeric Antigen Receptor Cell Therapy

Chimeric Antigen Receptor Cell Therapy

  • $ 7995
  • Industry report
  • February 2019

Chimeric Antigen Receptor Cell TherapySummaryChimeric Antigen Receptor (CAR) cell therapy is an Immuno-Oncology (IO) approach that has gained increasing momentum in the past few years.Despite having demonstrated ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, Japan, Europe, World, North America
Interventional Oncology Market by Product, Procedures, Cancer - Global Forecast to 2024

Interventional Oncology Market by Product, Procedures, Cancer - Global Forecast to 2024

  • $ 5650
  • Industry report
  • March 2019

The global interventional oncology market is projected to grow at a CAGR of 6.8% during the forecast periodInterventional oncology refers to the use of minimally invasive procedures performed for the diagnosis, ...

  • Industries : General Medicine and Specialty Medicine, Healthcare, Therapy, Oncology
  • Countries : United States, North America
Exosome Research Products Market by Product and Services, Application And End User - Global Forecast to 2024

Exosome Research Products Market by Product and Services, Application And End User - Global Forecast to 2024

  • $ 5650
  • Industry report
  • February 2019

High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products marketThe global exosome research products market is ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Global DNA Probes-Based Diagnostics Industry

Global DNA Probes-Based Diagnostics Industry

  • $ 5600
  • Industry report
  • May 2019

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, ...

  • Industries : Pathology, Cancer, Genomics Proteomics and Enabling Technology, Diagnostics, Chronic Disease
  • Countries : World, APAC, Japan, Europe, United States, Canada
Global Prostate Cancer Therapeutics Industry

Global Prostate Cancer Therapeutics Industry

  • $ 5600
  • Industry report
  • May 2019

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies.The report provides separate comprehensive analytics ...

  • Industries : Therapy
  • Countries : World, United States, Europe, Canada, North America
Colorectal Cancer Therapeutics: Global Markets

Colorectal Cancer Therapeutics: Global Markets

  • $ 5500
  • Industry report
  • March 2019

Report Scope:This report is a business analysis that examines market trends for colorectal cancer therapeutics. The report includes sections on the following topics - - Current prevalence of colorectal ...

  • Industries : Therapy
  • Countries : World
Cancer Profiling and Pathways: Technologies and Global Markets

Cancer Profiling and Pathways: Technologies and Global Markets

  • $ 4950
  • Industry report
  • March 2019

Report Scope:Cancer biomarkers have gained significant importance in the drug-development process, and the market is an emerging segment.To gain an understanding of the market dynamics, market size and ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology
  • Countries : World
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019SummaryCytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen ...

  • Industries : Therapy, Medical Biotechnology, Oncology, Cancer, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : United States, World
Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019SummaryTumo ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : United States, World
Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019SummaryRho ...

  • Industries : Therapy, Pharmaceutical, Drug Development, Health Services
  • Countries : United Kingdom, World, United States
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2019

Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2019SummaryRecepto ...

  • Industries : Cancer, Therapy, Pathology, Pharmaceutical
  • Countries : United States, World
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019SummaryInterleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen ...

  • Industries : Therapy, Pharmaceutical, Pathology, Cancer, Medical Biotechnology
  • Countries : World, United States
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2019

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2019SummaryNT 3 Growth Factor Receptor (TrkC ...

  • Industries : Cancer, Pathology
  • Countries : World, United States
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2019

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Macrophage ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’T Cell Surface Glycoprotein ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : World, United States
Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019SummaryRetinoic Acid Recepto ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H1 2019

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog ...

  • Industries : Therapy, Oncology, Medical Biotechnology
  • Countries : World, United States, Australia
Angiopoietin 1 Receptor - Pipeline Review, H1 2019

Angiopoietin 1 Receptor - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, Australia, World
Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2019

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Toll Like Receptor 4 - Pipeline Review, H1 2019’; Toll Like Receptor 4 (hToll ...

  • Industries : Pathology, Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, World
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019SummaryBaculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibito ...

  • Industries : Therapy, Cancer, Pharmaceutical, Pathology, Medical Biotechnology
  • Countries : United States, World
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2019

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2019SummaryTumor Necrosis Factor Receptor Superfamily ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : World, United States
Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2019

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2019SummaryInduced Myeloid Leukemia Cell Differentiation ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, World
Global Cervical Cancer Therapeutics Market 2019-2023

Global Cervical Cancer Therapeutics Market 2019-2023

  • $ 2500
  • Industry report
  • May 2019

About this marketThe advancements in diagnostics are one of the key factors expected to trigger the cervical cancer therapeutics market during the forecast period. Many medical devices companies are focusing ...

  • Industries : Cancer
  • Countries : United States, World, North America
Global Cancer Biologics Market 2019-2023

Global Cancer Biologics Market 2019-2023

  • $ 2500
  • Industry report
  • April 2019

About this marketThe rising global incidences of cancer are likely to impact the market’s growth during the forecast period. Increasing prevalence of environmental factors including tobacco smoking and ...

  • Industries : Cancer, Medical Biotechnology
  • Countries : World
Global Non-Small Cell Lung Cancer Drugs Market 2019-2023

Global Non-Small Cell Lung Cancer Drugs Market 2019-2023

  • $ 2500
  • Industry report
  • March 2019

About this marketThe increasing prevalence and incidence of non-small cell lung cancer are one of the primary factors driving the global non-small cell lung cancer drugs market growth. The growing risk ...

  • Industries : Cancer
  • Countries : World
Global Lung Cancer Therapeutics Market 2019-2023

Global Lung Cancer Therapeutics Market 2019-2023

  • $ 2500
  • Industry report
  • March 2019

About this marketThe global lung cancer therapeutics market has witnessed significant growth in recent years, primarily due to the increasing approval of immunomodulators. Vendors are conducting research ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : World
Global Esophageal Cancer Drugs Market 2019-2023

Global Esophageal Cancer Drugs Market 2019-2023

  • $ 2500
  • Industry report
  • March 2019

About this marketThe increasing incidence of esophageal cancer owing to factors including smoking, genetic mutations, obesity, and alcohol consumption has triggered the esophageal cancer drugs market growth ...

  • Industries : Cancer
  • Countries : World, United States
Global Blood Cancer Therapeutics Market 2019-2023

Global Blood Cancer Therapeutics Market 2019-2023

  • $ 2500
  • Industry report
  • February 2019

About this marketLeukemia is the most common type of cancer in children and also accounts for the highest mortality rate among cancers in pediatric patients. The prevalence of leukemia has been increasing ...

  • Industries : Cancer, Pathology
  • Countries : World
Artificial Intelligence in Healthcare Market: World Market Analysis By Component, Technology, End User, By Region, By Country (2019 Edition): Forecast to 2024

Artificial Intelligence in Healthcare Market: World Market Analysis By Component, Technology, End User, By Region, By Country (2019 Edition): Forecast to 2024

  • $ 2400
  • Industry report
  • April 2019

Executive SummaryA comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Industries : Advanced IT, Healthcare
  • Countries : World, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on